Acetylsalicylic acid tablets 75 mg, Metoclopramide, solution for injection, 5 mg/ml, 2 ml, Spironolactone tablets/capsules 25 mg, Spironolactone tablets/capsules 50 mg, Metoprolol, tablets, 25 mg, Metoprolol, tablets, 50 mg, Isosorbide, tablets, 10 mg, Methylprednisolone, powder andsolvent for injection solution, 500 mg each, Methylprednisolone, tablets, 4 mg each (INN: Acetylsalicylic acid, Metoclopramide, Spironolactone, Metoprolol, Isosorbide dinitrate, Methylprednisolone)
By: Maryniak Diana📍 UkraineClosed
Key Information
| Reference | GB-UA-2026-09-07-001114-a |
|---|
| Deadline | Sep 10, 2026 12:00 AM |
|---|
| Estimated Value | UAH 7,553,830.00 |
|---|
| Category | Advertising & Media |
|---|
| Competition Type | ICB |
|---|
| Funding Source | Self-Funded |
|---|
| Country | Ukraine |
|---|
| Address | 79495, Ukraine, Lviv region, Vinnyki, Ivasyuka V. street, building 31 |
|---|
| Published | Sep 7, 2026 |
|---|
Description
Acetylsalicylic acid tablets 75 mg, Metoclopramide, solution for injection, 5 mg/ml, 2 ml, Spironolactone tablets/capsules 25 mg, Spironolactone tablets/capsules 50 mg, Metoprolol, tablets, 25 mg, Met...
Full details are available after unlocking this tender.